NCT00470990View on ClinicalTrials.gov

Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hypogonadism
Interventions
DRUG

GnRH antagonist (Acyline)

3 Subcutaneous injections (300 mcg/kg) over 36 days

Trial Locations (1)

02143

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00470990 - Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men | Biotech Hunter | Biotech Hunter